Leiden chemists discovered a new mechanism which might explain how multiple sclerosis shifts to a more severe form. Their findings contribute to unraveling the mysterious course of the disease. They have published their findings ...
Jan 14, 2019
0
100
A biomarker for multiple sclerosis that could be an early warning for the disease has shown promise in both human and animal testing.
Dec 19, 2018
0
1145
(HealthDay)—Rates of multiple sclerosis (MS) relapse decrease during pregnancy but increase postpartum, according to a study published online Oct. 23 in Neurology.
Nov 20, 2018
0
2
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...
(HealthDay)—Among pediatric patients with relapsing multiple sclerosis, fingolimod is associated with a lower rate of relapse but a higher rate of serious adverse events than interferon beta-1a, according to a study published ...
Sep 13, 2018
0
2
Imagine waking up to a world that blurs in front of you. Heading to the kitchen for breakfast, you're hit with a wave of exhaustion, and your arms and legs feel like lead. This is the reality for the more than 400,000 people ...
Aug 30, 2018
0
25
A new, highly accurate MRI technique can monitor iron levels in the brains of multiple sclerosis (MS) patients and help identify those at a higher risk for developing physical disability, according to a study published in ...
Jul 17, 2018
0
4
(HealthDay)—Various clinical symptoms precede the diagnosis of multiple sclerosis (MS) by several years, according to a study published online May 8 in the Annals of Neurology.
May 21, 2018
0
2
Exposure to a toxin primarily found in sheep could be linked to the development of multiple sclerosis (MS) in humans, new research suggests.Carried out by the University of Exeter and MS Sciences Ltd., the study has found ...
Apr 23, 2018
0
25
MS in the 21st Century, an initiative co-chaired by Royal Holloway, University of London Professor of Neuropsychology, Dawn Langdon has published their new manuscript "Unmet needs, burden of treatment, and patient engagement ...
Mar 5, 2018
0
6
